Specifically, the identification of pIgR in serum EVs of hepatocellular carcinoma (HCC) patients is linked to enhancing cancer stemness in HCC cells, thereby contributing to the initiation and progression of liver cancer [57]. This evidence concerns the gene PIGR and hepatocellular carcinoma.